Globe Newswire

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous... (continue reading...)

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of... (continue reading...)

New York, NY, May 14, 2024 (GLOBE NEWSWIRE) -- Hudson Acquisition I Corp. (NASDAQ: “HUDA”) today announced it has signed a letter agreement with Aiways Automobile Europe GmbH (“Aiways Europe”) for a business combination (the “de-SPAC”). The shareholders of Aiways Europe will receive newly issued shares of HUDA common stock in an aggregate amount representing an equity valuation of approximately US$400 million.

The de-SPAC is expected to close on... (continue reading...)

VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX: III) announces the Toronto Stock Exchange (the “TSX”) has accepted the Company’s Notice of Intention to make a Normal Course Issuer Bid (the “Bid”) to be transacted through the facilities of the TSX or alternative Canadian trading systems.

Pursuant to the Bid, the Company may purchase up to 809,357 common shares, which... (continue reading...)

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Exscientia p.l.c (NASDAQ: EXAI) between March 23, 2022 and February 12, 2024, both dates inclusive (the “Class Period”), of the important June 25, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Exscientia securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees... (continue reading...)